News

IDIBELL organizes the first workshop of the European project IT-Liver

Next September 25, 26 and 27 the Institute of Catalan Studies hosts the first working meeting of the European IT-Liver Project included in the Programme Marie Curie ITN (Initial Training Network). IT-Liver project’s mission is to provide a multidisciplinary and intersectorial Research Training Programme for young researchers, so as to prepare them for leading roles […]

Leer más about IDIBELL organizes the first workshop of the European project IT-Liver

A project of the IDIBELL awards the grant of the Sandra Ibarra Foundation of Solidarity against Cancer

On September 17 took place the delivery of the “IV ghd Grants” for breast cancer research with a ceremony attended by the presence of Sandra Ibarra, president of the Foundation, Manel Esteller, patron of the Foundation, Candela Calle, general director of the Catalan Institute of Oncology (ICO) and Thys Niermeyer, general director of ghd Spain. […]

Leer más about A project of the IDIBELL awards the grant of the Sandra Ibarra Foundation of Solidarity against Cancer

Brain fixes the information that receives during the day on our memory while we sleep

Our brain accumulates information during the day but how do we register it in our memory? What makes this memory lasts over time? One of the main mechanisms is the consolidation of memory. From all that we see or learn during the day, brain filters what we forget and what we remember. The optimal moment […]

Leer más about Brain fixes the information that receives during the day on our memory while we sleep

IDIBELL participates at the Researcher’s Night 2013 in Barcelona

On September 27 Biocomunica’t ‘ T (www.biocomunicat.com) organizes in Barcelona a new edition of the Researcher’s Night, a European science spreading project of the 7th Framework Programme of the European Union which will take place simultaneously in more than 300 European cities. The goal of the Reseachercher’s Night is to show the contribution of scientists […]

Leer más about IDIBELL participates at the Researcher’s Night 2013 in Barcelona

High levels of RANK protein interferes with the differentiation of mammary cells

Researchers of the Transformation and Metastasis research group at Bellvitge Biomedical Research Institute (IDIBELL), led by Eva González-Suárez, have shown that overexpression of RANK signalling pathway interferes with the differentiation of the cells that form the mammary glands. This produces an accumulation of undifferentiated cells that finally leads to tumor development. In previous studies, the […]

Leer más about High levels of RANK protein interferes with the differentiation of mammary cells

Discovered one of the mechanism that influences aggressiveness in Ewing’s Sarcoma

Caveolin-1 participates in the formation of new blood vessels around the tumor, facilitating growth and proliferation The finding opens the door to the investigation of new therapies against this childhood cancer Angiogenesis and solid tumors Future therapies Article’s reference EphA2-induced angiogenesis in Ewing sarcoma celles works through bGFG production and is dependent on caveolin-1.

Leer más about Discovered one of the mechanism that influences aggressiveness in Ewing’s Sarcoma

Improvement in the diagnosis of testosterone deficiency syndrome in men allows an early treatment

The testosterone deficiency syndrome (TDS) is a clinical and biochemical syndrome associated with advancing age. It Is produced by a gradual drop in testosterone levels which affects the sexual sphere, leading to a decrease in sexual desire and morning erections, as well as decreasing the quality and frequency of erections. It can also affect the […]

Leer más about Improvement in the diagnosis of testosterone deficiency syndrome in men allows an early treatment

IDIBELL’s researcher Eva González-Suárez awarded with a grant from Susan G. Komen® to investigate new therapies in breast cancer

The research group leader in transformation and metastasis of the Bellvitge Biomedical Research Institute (IDIBELL), Eva González-Suárez, has been awarded with a research grant from Susan G. Komen®, the world’s leading breast cancer organization. The project is funded with 450 000 dollars for the next three years. Komen was founded in 1982 with the goal […]

Leer más about IDIBELL’s researcher Eva González-Suárez awarded with a grant from Susan G. Komen® to investigate new therapies in breast cancer
Scroll to Top